Translational Development Acquisition Corp. — Director's Dealing 2024

Dec 20, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Translational Development Acquisition Corp. (TDAC)
CIK: 0001926599
Period of Report: 2024-12-20

Reporting Person: Hoffman Michael B (Director, Chief Executive Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Class B Ordinary Shares	$		Class A Ordinary Shares (4657500)		Indirect

Footnotes

F1: As described in the issuer's registration statement on Form S-1 (File No. 333-282763) under the heading "Description of Securities - Ordinary Shares," the Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation issuer's initial business combination, on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and certain anti-dilution rights and has no expiration date.

F2: Includes up to 607,500 shares subject to forfeiture by TDAC Partners LLC (the "Sponsor") depending on the extent to which the underwriters' option to purchase additional units is exercised.

F3: The Reporting Person is a managing member of the Sponsor and as a result may be deemed to beneficially own the securities held of record by the Sponsor. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.